Oxford firms join forces to scale up production of COVID-19 antigens
In the wake of the pandemic, the strategic partnership aims to increase antigen production for diagnostic kits and vaccine development
In the wake of the pandemic, the strategic partnership aims to increase antigen production for diagnostic kits and vaccine development
Horizon Discovery and Pharmahungary have reported a micro-RNA compound suitable for further development
Initial shipments of FLIR A400/A700 thermal sensor solution will be prioritized for those responding to the COVID-19 virus
New IgM and IgG antibody assays will help indicate whether a person has developed immunity against COVID-19
The scientific community is working at full speed to fight the severe acute respiratory syndrome
The rapid delivery program is designed to provide critical laboratory equipment in this time of need
Samples from those who had COVID-19 could reveal true infection rate, lethality and vaccines
The partnership with Primer Design aims to distribute the Genesig CE-IVD & FDA-EUA COVID-19 qPCR kit to Europe and the U.S.
The RAPIDPoint 500e blood gas analyzer aims to meet the unprecedented demand for blood gas testing in coronavirus patients
OPENCORONA consortium awarded €3 million funding by Horizon 2020 to support emergency research and development against the COVID-19 outbreak
The Abbott ID NOW™ COVID-19 test aims to bring rapid testing to the front lines of the global pandemic
These are some of the first antibody detection tests to be CE marked in Europe and available for COVID-19 testing
This clinical trial aims to test the effects of potential drug treatments for patients with the novel coronavirus
The Xpert Xpress SARS-CoV-2 test is designed for the qualitative detection of the virus causing COVID-19
The collaboration aims to develop novel, targeted treatments to address significant unmet needs
Coronavirus is said to be detected using Iceni Diagnostics’ rapid, point-of-care screening technology, which distinguishes it from influenza
Scientists say early data, generated with new NGS research panel from Thermo Fisher Scientific, suggest coronavirus is genetically stable, and could increase the effectiveness of vaccines in development
This critical appeal was made to the life sciences sector in order to tackle the spread of coronavirus
Hardy Diagnostics has announced the release of a rapid test for patients suspected of COVID-19 infection
Clinical laboratories can immediately begin using this kit to detect SARS-CoV-2
Sartorius supports the development of the first vaccine candidate against the novel coronavirus to enter clinical trials
AI-driven proteogenomic analysis company applies single-cell analysis expertise to develop treatments for COVID-19
Roche Group has provided an update on the various actions the company is taking to address the COVID-19 pandemic
The test will be used on the m2000 RealTime system that is currently available in hospitals and molecular laboratories in the U.S.
The panel covers entire genome of the new coronavirus to facilitate complete genome sequencing and support epidemiological studies